Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Stolte

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
European Journal of Neurology|March 12, 2021
Reply to: Minimal detectable change and minimal clinically important differences in spinal muscular atrophy patientsBenjamin Stolte, Christoph Kleinschnitz, Tim Hagenacker
Current Pharmaceutical Design|March 30, 2022
Treatment of Adult Spinal Muscular Atrophy: Overview and Recent DevelopmentsSvenja Brakemeier, Benjamin Stolte, Christoph Kleinschnitz, et al.
Cephalalgia : an International Journal of Headache|May 22, 2014
Vestibular migraineBenjamin Stolte, Dagny Holle, Steffen Naegel, et al.
Journal of the American Academy of Dermatology|October 15, 2011
No evidence for a causal role of Merkel cell polyomavirus in keratoacanthomaUlrike Wieland, Nina Scola, Benjamin Stolte, et al.
Journal of Clinical Medicine|August 12, 2022
Total Plasma Exchange in Neuromuscular Junction Disorders-A Single-Center, Retrospective Analysis of the Efficacy, Safety and Potential Diagnostic Properties in Doubtful DiagnosisAndreas Totzeck, Michael Jahn, Benjamin Stolte, et al.
International Journal of Molecular Sciences|November 2, 2019
Neurofilament Heavy Chain and Tau Protein Are Not Elevated in Cerebrospinal Fluid of Adult Patients with Spinal Muscular Atrophy during Loading with NusinersenAndreas Totzeck, Benjamin Stolte, Kathrin Kizina, et al.
Brain Sciences|September 28, 2021
Assessment of Bulbar Function in Adult Patients with 5q-SMA Type 2 and 3 under Treatment with NusinersenSvenja Brakemeier, Benjamin Stolte, Andreas Thimm, et al.
European Journal of Neurology|May 9, 2023
Corneal confocal microscopy reveals small nerve fibre loss correlating with motor function in adult spinal muscular atrophyAndreas Thimm, Svenja Brakemeier, Merve Dag, et al.
Muscle & Nerve|October 3, 2024
Performance fatigability in adults with spinal muscular atrophy treated long-term with nusinersenBenjamin Stolte, Svenja Neuhoff, Jaqueline Lipka, et al.
Frontiers in Neurology|February 10, 2022
Assessment of Health-Related Quality of Life in Adult Spinal Muscular Atrophy Under Nusinersen Treatment-A Pilot StudyAndreas Thimm, Svenja Brakemeier, Kathrin Kizina, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Neurology|March 12, 2021
Reply to: Minimal detectable change and minimal clinically important differences in spinal muscular atrophy patientsBenjamin Stolte, Christoph Kleinschnitz, Tim Hagenacker
Current Pharmaceutical Design|March 30, 2022
Treatment of Adult Spinal Muscular Atrophy: Overview and Recent DevelopmentsSvenja Brakemeier, Benjamin Stolte, Christoph Kleinschnitz, et al.
Cephalalgia : an International Journal of Headache|May 22, 2014
Vestibular migraineBenjamin Stolte, Dagny Holle, Steffen Naegel, et al.
Journal of the American Academy of Dermatology|October 15, 2011
No evidence for a causal role of Merkel cell polyomavirus in keratoacanthomaUlrike Wieland, Nina Scola, Benjamin Stolte, et al.
Journal of Clinical Medicine|August 12, 2022
Total Plasma Exchange in Neuromuscular Junction Disorders-A Single-Center, Retrospective Analysis of the Efficacy, Safety and Potential Diagnostic Properties in Doubtful DiagnosisAndreas Totzeck, Michael Jahn, Benjamin Stolte, et al.
International Journal of Molecular Sciences|November 2, 2019
Neurofilament Heavy Chain and Tau Protein Are Not Elevated in Cerebrospinal Fluid of Adult Patients with Spinal Muscular Atrophy during Loading with NusinersenAndreas Totzeck, Benjamin Stolte, Kathrin Kizina, et al.
Brain Sciences|September 28, 2021
Assessment of Bulbar Function in Adult Patients with 5q-SMA Type 2 and 3 under Treatment with NusinersenSvenja Brakemeier, Benjamin Stolte, Andreas Thimm, et al.
European Journal of Neurology|May 9, 2023
Corneal confocal microscopy reveals small nerve fibre loss correlating with motor function in adult spinal muscular atrophyAndreas Thimm, Svenja Brakemeier, Merve Dag, et al.
Muscle & Nerve|October 3, 2024
Performance fatigability in adults with spinal muscular atrophy treated long-term with nusinersenBenjamin Stolte, Svenja Neuhoff, Jaqueline Lipka, et al.
Frontiers in Neurology|February 10, 2022
Assessment of Health-Related Quality of Life in Adult Spinal Muscular Atrophy Under Nusinersen Treatment-A Pilot StudyAndreas Thimm, Svenja Brakemeier, Kathrin Kizina, et al.
Pageof 4